Based on previous experience [29], two patients of our cohort with trisomy 21 mosaic and GATA1 mutation were successfully treated with a reduced intensity regimen for DS-AMKL patients (according to treatment recommendation of the ML-DS 2006 registry). Here, GATA1 is linked to acute megakaryoblastic leukemia.